Drug Shortage Report for BUPIVACAINE HYDROCHLORIDE INJECTION, USP
| Report ID | 210780 |
| Drug Identification Number | 02488930 |
| Brand name | BUPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | Bupivacaine Hydrochloride |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | BUPIVACAINE HYDROCHLORIDE |
| Strength(s) | 7.5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | RETROBULBAR EPIDURAL |
| Packaging size | AIN03056 |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2024-04-12 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2024-04-11 |
| Shortage status | Avoided shortage |
| Updated date | 2024-04-11 |
| Company comments | Product remains available. Baxter continues to work to mitigate any potential supply risk. Contact your Baxter Pharmacy representative for additional information. |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2024-04-11 | French | Compare |
| v14 | 2024-04-11 | English | Compare |
| v13 | 2024-04-02 | English | Compare |
| v12 | 2024-01-22 | English | Compare |
| v11 | 2024-01-10 | French | Compare |
| v10 | 2024-01-10 | English | Compare |
| v9 | 2024-01-10 | French | Compare |
| v8 | 2024-01-10 | English | Compare |
| v7 | 2024-01-05 | French | Compare |
| v6 | 2024-01-05 | English | Compare |
| v5 | 2023-11-24 | French | Compare |
| v4 | 2023-11-24 | English | Compare |
| v3 | 2023-11-24 | English | Compare |
| v2 | 2023-11-17 | French | Compare |
| v1 | 2023-11-17 | English | Compare |
Showing 1 to 15 of 15